SCHEMBL1675289

SCHEMBL1675289

Cc1ccc(CN(C)c2ncnc3ccc(-c4ccc(CO)n4C)cc23)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.59
CLK4 Q9HAZ1 16/20 0.50
CLK1 P49759 5/20 0.50
CLK2 P49760 4/20 0.50
DYRK1B Q9Y463 4/20 0.50
DYRK1A Q13627 3/20 0.50
CYP1A2 P05177 12/20 0.45
CYP3A4 P08684 12/20 0.45
CYP2D6 P10635 12/20 0.45
CYP2C19 P33261 12/20 0.45
TSHR P16473 10/20 0.45
LMNA P02545 9/20 0.45
USP2 O75604 7/20 0.45
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 8/20 0.44
HSD17B10 Q99714 7/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
MAPK1 P28482 6/20 0.43
HPGD P15428 4/20 0.43
CYP2C9 P11712 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675063 0.84 CDK2 (0.58) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675160 0.82 CLK4 (0.71) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675141 0.75 CLK4 (0.66) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675262 0.75 CDK2 (1.00) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675242 0.72 CLK1 (0.73) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675230 0.68 CLK4 (0.60) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675038 0.67 CLK4 (0.80) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675078 0.67 CLK4 (1.00) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675012 0.65 CLK4 (0.51) CDK2CLK4CLK1CLK2DYRK1B
SCHEMBL1675098 0.64 CLK4 (0.86) CDK2CLK4CLK1CLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed